ALTRIA CLIENT SERVICES LLC for ALTRIA CLIENT SERVICES LLC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 4368/S 2131 FY 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill; provisions related to FDA rulemaking and enforcement efforts related to illicit electronic nicotine delivery systems (ENDS) products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA ARBOLEDA | — |
| MICHELLE DIMAROB | — |
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Government Issues GOV
Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA ARBOLEDA | — |
| MICHELLE DIMAROB | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Labor Issues/Antitrust/Workplace LBR
HJRes 59 and SJRes 25 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Adverse Effect Wage Rate Methodology for the Temporary Employment of H-2A Nonimmigrants in Non-Range Occupations in the United States"
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOEL | — |
| PHIL PARK | — |
| TODD WALKER | — |
Taxation/Internal Revenue Code TAX
Discussions concerning draft legislation to amend corporate tax rates Discussions concerning draft legislation on dividend tax rates Discussions regarding federal excise taxes on tobacco products Discussions concerning amendments to Section 958(b)(4) of the Internal Revenue Code Discussions concerning the full expensing of capital expenditures per the 2017 Tax Cuts & Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Tobacco TOB
HR 901 - Disposable ENDS Product Enforcement Act of 2023; all provisions ANPRM for Docket No. FDA-2017-N-6189 Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products FDA-2021-N-1309, Proposed Rule regarding Tobacco Product Standard for Characterizing Flavors in Cigars FDA-2021-N-1349, Proposed Rule regarding Tobacco Product Standard for Menthol in Cigarettes Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA ARBOLEDA | — |
| MICHELLE DIMAROB | — |
| CYNTHIA HAYDEN | — |
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.